On Friday, July 29, investors await quarterly results from Anheuser-Busch Inbev (BUD) and the first estimate of second quarter GDP. Before the markets open, the beverage maker is expected to release earnings of $1.00 a share on sales of $10.93 billion. During the same quarter a year ago, the company reported profit of $1.21 a share with revenue of $11.05 billion. Investors will be looking for updates on the company's proposed $104 billion acquisition of SABMiller. Other companies including United Parcel Service (UPS) , Xerox Corporation (XRX) , Merck (MRK) and Cigna (CIG) report before the markets open. On the economic calendar, the first estimate of second quarter gross domestic product is released at 8:30am Eastern. Analysts expect economic growth of 2.6 percent during the quarter, ahead of the 1.1 percent growth seen during the first quarter. TheStreet's Scott Gamm reports from Wall Street.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.